Centene Corporation (CNC)
NYSE: CNC
· Real-Time Price · USD
29.00
0.51 (1.79%)
At close: Aug 18, 2025, 3:59 PM
29.00
0.00%
After-hours: Aug 18, 2025, 07:59 PM EDT
Centene Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Other Operating Segment Revenue | 4.92B |
| Other Operating Segment Revenue Growth | n/a |
| Medicaid Segment Revenue | 124.45B |
| Medicaid Segment Revenue Growth | n/a |
| Commercial Segment Revenue | 33.7B |
| Commercial Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.04B | 3.35B | 3.23B | 3.06B | 2.89B | 3.22B | 3.49B | 3.05B | 3.02B | 3.01B | 3.2B | 2.85B | 2.8B | 2.75B | 2.84B | 2.54B | 2.14B | 2.23B | 3.1B | 2.88B | 2.63B | 2.73B | 1.73B | 1.62B | 1.57B | 1.61B | 1.73B | 2.11B | 1.42B | 1.49B | 1.26B | 1.03B | 1.06B | 1.09B | 1.19B | 1.07B | 1.08B | 796M | 571M | 512M | 489M | 451M |
| Selling, General, and Administrative Revenue Growth | -9.45% | +3.78% | +5.69% | +5.63% | -10.07% | -7.74% | +14.44% | +1.06% | +0.17% | -5.85% | +12.37% | +1.64% | +2.00% | -3.41% | +12.02% | +18.61% | -4.25% | -27.87% | +7.42% | +9.45% | -3.48% | +57.47% | +7.17% | +2.73% | -2.18% | -7.16% | -17.95% | +48.73% | -4.51% | +18.02% | +22.33% | -3.29% | -2.38% | -8.55% | +11.60% | -0.93% | +35.55% | +39.40% | +11.52% | +4.70% | +8.43% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |